AXA SA (AXAN)
Mexican Exchange · Mexico · prices in MXN · close of 15 Oct 2026
Key indicators
| Last close | MXN 869.74 |
|---|---|
| 52-week range | 795.49 – 946.34 |
| Return, 1 month / 3 months | +0.0% / −2.1% |
| Return, 1 year / 3 years | −2.8% / +100.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 34 |
| Volatility (1 year) | 20.8% |
| Worst drawdown (1 year) | -15.8% |
| Average daily value traded | 0.01M MXN |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AXA is a French insurance group based in Paris. It provides life, health, property and casualty insurance to individual customers and businesses, and it also offers savings and asset management services through its investment arm. The company operates across many countries in Europe, Asia and the Americas, serving retail clients as well as corporate and commercial customers with protection and risk coverage products.
AXA SA trades under the code AXAN on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AXA SA (AXAN) trades on the Mexican Exchange in Mexico. It last closed at MXN 869.74 on 15 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 162 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.8% and over the last three months it fell 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.5% | ||
| From 52-week high | -8.1% | ||
| Momentum | 41 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.1% | ||
| 6-month return | 7.1% | ||
| 12-month return, skipping the last month | -2.8% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.8% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M MXN | ||
| Zero-volume days | 98.3% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | −2.1% |
| 6 months | +7.1% |
| 1 year | −2.8% |
| 3 years | +100.6% |
| 5 years | +106.5% |
Signals
| 50-day / 200-day average | 873.82 / 816.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | MXN 46.9439 |
| 5 May 2025 | MXN 47.7895 |
| 30 Apr 2024 | MXN 36.0725 |
| 8 May 2023 | MXN 33.3639 |
| 6 May 2022 | MXN 32.7594 |
| 7 May 2021 | MXN 34.5534 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.